Frontlight ResearchEarly access
Haemophilia trials in Finland
4 of 7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleNuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
- Where
- Helsinki
- Age
- 12 years and over
- People
- 28 worldwide
- Run by
- Octapharma
See details and how to joinNCT05935358 - Phase 4Taking peopleNuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
- Where
- Helsinki
- Age
- 12 years and over
- People
- 28 worldwide
- Run by
- Octapharma
See details and how to joinNCT05936580 - Phase 4Taking peopleNuwiq Dosing and outcomes In the ManagEment of women/girls with haemophilia A Needing FVIII treatment for Surgery – an International, Open-label, Non-controlled study (NuDIMENSION)
- Where
- Helsinki
- People
- 17 worldwide
- Run by
- Octapharma AG
See details and how to join2022-502061-17-00 - Phase 4Taking peopleNuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER)
- Where
- Helsinki
- People
- 45 worldwide
- Run by
- Octapharma AG
See details and how to join2022-502060-21-00